Ethnic Differences in the Inflammatory Response in Systemic Inflammation
NCT00284869 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2006-09-13
Summary
The purpose of this study is to investigate putative ethnic differences in the proinflammatory response in human endotoxemia.
Conditions
- Endotoxemia
Interventions
- DRUG
-
LPS
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Christa Firbas, MD · Medical University of Vienna, Department of Clinical Pharmacology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- ECT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Completion
- 2006-04-30
Countries
- Austria
Study Locations
More Related Trials
-
(VIII): The Eight Study and Immunologic Response Sub-study
NCT05237024 ·Status: UNKNOWN
-
Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome.
NCT01343979 ·Status: COMPLETED
-
TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
NCT00789997 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Precision Immunology to Determine the Immune Response in Patients With COVID-19
NCT04360733 ·Status: UNKNOWN
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
PET Imaging of Endotoxin-induced iNOS Activation
NCT01407796 ·Status: COMPLETED ·Phase: PHASE1
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
NCT01224977 ·Status: UNKNOWN ·Phase: NA
-
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
NCT00429975 ·Status: TERMINATED ·Phase: PHASE4
-
Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
NCT04619693 ·Status: TERMINATED
-
Transcriptomic Responses for the Identification of Pathogens
NCT04878549 ·Status: RECRUITING
-
Characterizing the Immune Response and Neuronal Damage in COVID-19
NCT04510012 ·Status: COMPLETED
-
Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome
NCT06879535 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Fitness Prediction
NCT05078346 ·Status: COMPLETED
-
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 ·Status: UNKNOWN
-
COVID-19 Epidemic Response Study
NCT04357496 ·Status: WITHDRAWN
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients
NCT04784468 ·Status: UNKNOWN
-
Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)
NCT04452942 ·Status: UNKNOWN
-
Diagnosis and Management of Inflammatory and Infectious Diseases
NCT00557726 ·Status: RECRUITING
-
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
NCT00768534 ·Status: COMPLETED
-
Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.
NCT03876990 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome
NCT04346017 ·Status: COMPLETED ·Phase: NA
-
Mechanisms for Covid-19 Disease Complications
NCT04314232 ·Status: UNKNOWN
-
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
NCT04706390 ·Status: RECRUITING
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED